Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 28 out of 100. Prevention trials

Topic: Risk, prevention and care in population studies

Results At present, there is no cure for dementia. The results were promising, showing beneficial effects on cognitive performance, as even small individual changes across multiple risk factors can lead to favorable outcomes when combined (Kivipelto M, Mangialasche F, Ngandu T. Since the FINGER study demonstrated that prevention is possible through multidomain interventions, it became essential to adapt, expand, and optimize these findings through the World-Wide FINGERS initiative (Kivipelto M et al. Identifying individuals at higher risk may allow for the development of strategies to prevent or delay the onset of dementia. Longer follow-up periods are also needed to gather further results.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Marques, I. M. (2026). From FINGER to World-Wide FINGERS - multidomain interventions for risk reduction and prevention of dementia. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2026.10995

Vancouver

Marques IM. From FINGER to World-Wide FINGERS - multidomain interventions for risk reduction and prevention of dementia. European Psychiatry. 2026. doi:10.1192/j.eurpsy.2026.10995.

BibTeX

@article{marques2026-606c0968,
  author  = {Marques, I. M.},
  title   = {{From FINGER to World-Wide FINGERS - multidomain interventions for risk reduction and prevention of dementia}},
  journal = {European Psychiatry},
  year    = {2026},
  doi     = {10.1192/j.eurpsy.2026.10995},
  url     = {https://doi.org/10.1192/j.eurpsy.2026.10995}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This review states that there is currently no cure for dementia, while reporting that multidomain interventions showed promising beneficial effects on cognitive performance, since small changes across multiple risk factors can combine favorably. It notes that identifying higher-risk individuals may allow strategies to prevent or delay dementia onset, and that longer follow-up is needed.

Study details

How this study scored 28/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 27 of the 96 points it could be judged on, which is 28 of 100. Total 28 of 100.27 of the 96 points we could judge = 28 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 27 of the 96 points we could judge it on, which is 28 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (European Psychiatry)
Journal's citation record 1 / 4 European Psychiatry: journal h-index 143 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author I. M. Marques holds only 3 work(s), too few to judge a track record — left out of this score
Institution's track record 0 / 3 Unidade Local de Saúde de Coimbra: institution h-index 252 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 27 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 27 of the 96 points we could judge it on is 28 out of 100.
Total 28 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Related studies in Prevention trials

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Prevention trials

See all studies in Prevention trials →